
CNI Research (CNIRESLTD) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.8M
Gross Profit
2.7M
96.30%
Operating Income
269.0K
9.77%
Net Income
854.0K
31.01%
EPS (Diluted)
₹0.01
Balance Sheet Metrics
Total Assets
153.5M
Total Liabilities
410.0K
Shareholders Equity
153.1M
Debt to Equity
0.00
Cash Flow Metrics
Revenue & Profitability Trend
CNI Research Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 44.2M | 103.4M | 95.5M | 78.4M | -23.1M |
Cost of Goods Sold | 43.2M | 92.2M | 89.4M | 60.1M | 11.4M |
Gross Profit | 1.0M | 11.2M | 6.1M | 18.3M | -34.6M |
Gross Margin % | 2.3% | 10.8% | 6.4% | 23.3% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 697.0K | 210.0K | 114.0K | 50.0K |
Other Operating Expenses | 50.0M | 1.3M | 941.0K | 788.0K | 1.1M |
Total Operating Expenses | 50.0M | 2.0M | 1.2M | 902.0K | 1.2M |
Operating Income | -49.0M | 8.8M | 4.6M | 17.0M | -36.1M |
Operating Margin % | -110.9% | 8.6% | 4.8% | 21.7% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | 766.0K | 335.0K | 201.0K | 32.0K |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -48.8M | 8.5M | -8.6M | 17.2M | -36.1M |
Income Tax | 0 | 148.0K | 4.0K | 190.0K | 7.0K |
Effective Tax Rate % | 0.0% | 1.7% | 0.0% | 1.1% | 0.0% |
Net Income | -48.8M | 8.4M | -8.6M | 17.0M | -36.1M |
Net Margin % | -110.5% | 8.1% | -9.0% | 21.7% | 0.0% |
Key Metrics | |||||
EBITDA | -48.8M | 9.6M | 4.9M | 17.2M | -36.1M |
EPS (Basic) | ₹-0.43 | ₹0.07 | ₹-0.07 | ₹0.15 | ₹-0.31 |
EPS (Diluted) | ₹-0.43 | ₹0.07 | ₹-0.07 | ₹0.15 | ₹-0.31 |
Basic Shares Outstanding | 113588372 | 114804500 | 114804500 | 114804500 | 114804500 |
Diluted Shares Outstanding | 113588372 | 114804500 | 114804500 | 114804500 | 114804500 |
Income Statement Trend
CNI Research Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.2M | 8.2M | 7.5M | 2.3M | 2.9M |
Short-term Investments | 742.0K | 16.0M | - | - | - |
Accounts Receivable | 0 | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | - | 1.0K | -1.0K | 27.0K | - |
Total Current Assets | 34.9M | 25.0M | 8.2M | 14.1M | 3.5M |
Non-Current Assets | |||||
Property, Plant & Equipment | 6.0K | -1.0K | -1.0K | -1.0K | -1.0K |
Goodwill | 0 | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | -1.0K | -1.0K | - | -1.0K |
Total Non-Current Assets | 118.6M | 124.4M | 86.6M | 110.9M | 75.3M |
Total Assets | 153.5M | 149.4M | 94.8M | 125.0M | 78.8M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | 0 | 0 | 0 | 561.0K |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | 10.0K | - |
Total Current Liabilities | 410.0K | 230.0K | 171.0K | 455.0K | 678.0K |
Non-Current Liabilities | |||||
Long-term Debt | - | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | 1.0K | - | -1.0K | - |
Total Non-Current Liabilities | 0 | 1.0K | 0 | -1.0K | 0 |
Total Liabilities | 410.0K | 231.0K | 171.0K | 454.0K | 678.0K |
Equity | |||||
Common Stock | 114.8M | 114.8M | 114.8M | 114.8M | 114.8M |
Retained Earnings | - | 37.1M | 28.8M | 37.4M | 20.4M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 153.1M | 149.1M | 94.6M | 124.5M | 78.1M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 0 | 0 |
Working Capital | 34.5M | 24.7M | 8.0M | 13.6M | 2.8M |
Balance Sheet Composition
CNI Research Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -39.4M | 8.5M | -8.6M | 17.2M | -36.1M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -32.5M | 35.0K | -262.0K | -261.0K | -295.0K |
Operating Cash Flow | -71.9M | 7.8M | -9.2M | 16.9M | -36.4M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | -160.3M | -43.9M | -86.9M | -6.3M | -35.1M |
Investment Sales | 209.4M | 57.8M | 79.0M | 14.2M | 36.8M |
Investing Cash Flow | 49.1M | 13.9M | -7.8M | 7.9M | 1.7M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |
Free Cash Flow | -72.2M | 1.5M | 1.0M | 2.3M | -1.4M |
Net Change in Cash | -22.8M | 21.7M | -17.0M | 24.8M | -34.6M |
Cash Flow Trend
CNI Research Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-24.26
Price to Book
8.11
Price to Sales
307.10
PEG Ratio
0.37
Profitability Ratios
Profit Margin
2.27%
Operating Margin
9.77%
Return on Equity
-31.91%
Return on Assets
-31.82%
Financial Health
Current Ratio
85.03
Debt to Equity
0.00
Beta
-0.23
Per Share Data
EPS (TTM)
₹-0.44
Book Value per Share
₹1.32
Revenue per Share
₹0.05
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cniresltd | 1.6B | -24.26 | 8.11 | -31.91% | 2.27% | 0.00 |
Motilal Oswal | 557.5B | 20.45 | 5.03 | 22.47% | 37.00% | 138.95 |
Authum Investment | 506.3B | 12.37 | 3.44 | 28.87% | 93.88% | 7.18 |
Share India | 33.2B | 10.96 | 1.72 | 13.95% | 24.50% | 22.79 |
Shalimar Agencies | 27.0B | 645.33 | 25.93 | 10.13% | 5.31% | 64.93 |
Monarch Networth | 26.2B | 16.97 | 3.29 | 18.73% | 47.16% | 1.16 |
Financial data is updated regularly. All figures are in the company's reporting currency.